Increased insulin level can also indirectly stimulate tumor cell growth by increasing the bioavailability of insulin-like-growth-factor-1 (IGF-I) through glucogenesis, which can activate insulin receptors in various tissues including breast cells through stimulation of abnormal signaling cascade that can increase angiogenesis and reduced apoptosis [16,54]. The gene discussed is INSR; the disease is neoplasm.